Eqis Capital Management, Inc. Novo Nordisk A S Transaction History

Eqis Capital Management, Inc.

$1.17 Billion
Q2 2024

A detailed history of Eqis Capital Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 19,335 shares of NVO stock, worth $2.23 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

19,335

Previous 23,514 17.77%

Holding current value

$2.23 Million

Previous $3.02 Million 8.61%

% of portfolio

0.24%

Previous 0.25%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $512,805 - $613,936	-4,179 Reduced 17.77%	19,335 $2.76 Million
Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $478,895 - $637,464	-4,690 Reduced 16.63%	23,514 $3.02 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $417,218 - $501,203	4,753 Added 20.27%	28,204 $2.92 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $2.13 Million - $4.68 Million	23,451 New	23,451 $2.13 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $1.03 Million - $1.24 Million	7,813 New	7,813 $1.24 Million
Q2 2022 Aug 08, 2022	SELL	$103.24 - $121.81 $252,421 - $297,825	-2,445 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $227,629 - $275,160	2,445 New	2,445 $272,000
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $342,207 - $386,909	-5,103 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$63.89 - $73.8 $28,558 - $32,988	-447 Reduced 8.05%	5,103 $356,000
Q3 2020 Nov 10, 2020	SELL	$63.69 - $70.22 $57,193 - $63,057	-898 Reduced 13.93%	5,550 $385,000
Q2 2020 Aug 10, 2020	BUY	$58.54 - $67.94 $180,771 - $209,798	3,088 Added 91.9%	6,448 $422,000
Q1 2020 May 12, 2020	SELL	$49.46 - $64.78 $62,863 - $82,335	-1,271 Reduced 27.45%	3,360 $212,000
Q4 2019 Jan 24, 2020	SELL	$49.86 - $58.26 $27,871 - $32,567	-559 Reduced 10.77%	4,631 $268,000
Q3 2019 Nov 05, 2019	SELL	$47.54 - $53.43 $1,663 - $1,870	-35 Reduced 0.67%	5,190 $268,000
Q2 2019 Jul 18, 2019	SELL	$46.79 - $52.47 $90,304 - $101,267	-1,930 Reduced 26.97%	5,225 $267,000
Q1 2019 Apr 18, 2019	BUY	$46.36 - $52.63 $8,344 - $9,473	180 Added 2.58%	7,155 $374,000
Q4 2018 Jan 25, 2019	SELL	$41.54 - $47.25 $8,308 - $9,450	-200 Reduced 2.79%	6,975 $321,000
Q3 2018 Oct 17, 2018	SELL	$46.76 - $51.24 $6,593 - $7,224	-141 Reduced 1.93%	7,175 $350,000
Q2 2018 Jul 27, 2018	SELL	$44.29 - $50.42 $14,837 - $16,890	-335 Reduced 4.38%	7,316 $337,000
Q1 2018 Apr 06, 2018	SELL	$48.49 - $58.14 $38,016 - $45,581	-784 Reduced 9.29%	7,651 $377,000
Q4 2017 Jan 25, 2018	SELL	$47.53 - $53.73 $50,476 - $57,061	-1,062 Reduced 11.18%	8,435 $453,000
Q3 2017 Oct 03, 2017	BUY	$41.15 - $49.22 $390,801 - $467,442	9,497	9,497 $457,000

Others Institutions Holding NVO

# of Institutions

1,988

Shares Held

318M

Call Options Held

5.16M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $260B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account

Eqis Capital Management, Inc. Novo Nordisk A S Transaction History